Dynamic Contrast Enhanced Study in Multiparametric Examination of the Prostate-Can We Make Better Use of It?
- PMID: 35736872
- PMCID: PMC9231365
- DOI: 10.3390/tomography8030124
Dynamic Contrast Enhanced Study in Multiparametric Examination of the Prostate-Can We Make Better Use of It?
Abstract
We sought to investigate whether quantitative parameters from a dynamic contrast-enhanced study can be used to differentiate cancer from normal tissue and to determine a cut-off value of specific parameters that can predict malignancy more accurately, compared to the obturator internus muscle as a reference tissue. This retrospective study included 56 patients with biopsy proven prostate cancer (PCa) after multiparametric magnetic resonance imaging (mpMRI), with a total of 70 lesions; 39 were located in the peripheral zone, and 31 in the transition zone. The quantitative parameters for all patients were calculated in the detected lesion, morphologically normal prostate tissue and the obturator internus muscle. Increase in the Ktrans value was determined in lesion-to-muscle ratio by 3.974368, which is a cut-off value to differentiate between prostate cancer and normal prostate tissue, with specificity of 72.86% and sensitivity of 91.43%. We introduced a model to detect prostate cancer that combines Ktrans lesion-to-muscle ratio value and iAUC lesion-to-muscle ratio value, which is of higher accuracy compared to individual variables. Based on this model, we identified the optimal cut-off value with 100% sensitivity and 64.28% specificity. The use of quantitative DCE pharmacokinetic parameters compared to the obturator internus muscle as reference tissue leads to higher diagnostic accuracy for prostate cancer detection.
Keywords: magnetic resonance imaging; muscle; perfusion; permeability; prostate cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Quantitative contrast-enhanced perfusion kinetics in multiparametric MRI in differentiating prostate cancer from chronic prostatitis: results from a pilot study.Br J Radiol. 2019 Aug;92(1100):20190181. doi: 10.1259/bjr.20190181. Epub 2019 Jun 11. Br J Radiol. 2019. PMID: 31184934 Free PMC article.
-
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization.Eur J Radiol. 2019 Sep;118:51-57. doi: 10.1016/j.ejrad.2019.07.002. Epub 2019 Jul 2. Eur J Radiol. 2019. PMID: 31439258
-
Quantitative assessment of dynamic 18F-flumethycholine PET and dynamic contrast enhanced MRI in high risk prostate cancer.Br J Radiol. 2019 Feb;92(1094):20180568. doi: 10.1259/bjr.20180568. Epub 2018 Nov 14. Br J Radiol. 2019. PMID: 30383459 Free PMC article.
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
-
Multiparametric magnetic resonance imaging for transition zone prostate cancer: essential findings, limitations, and future directions.Abdom Radiol (NY). 2017 Nov;42(11):2732-2744. doi: 10.1007/s00261-017-1184-6. Abdom Radiol (NY). 2017. PMID: 28702787 Review.
Cited by
-
Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate-Unnecessary or Underutilised? A Narrative Review.Diagnostics (Basel). 2023 Nov 20;13(22):3488. doi: 10.3390/diagnostics13223488. Diagnostics (Basel). 2023. PMID: 37998624 Free PMC article. Review.
References
-
- Rosenkrantz A., editor. MRI of the Prostate: A Practical Approach. Thieme; New York, NY, USA: Stuttgart, Germany: Delhi, India: Rio de Janeiro, Brazil: 2016.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical